Eduardo Sprinz

机构：Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre · ORCID：0000-0003-4343-8304

发表论文 162 篇 · 总被引 9622 次 · h-index 34

代表论文

• Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia (2023 · JAMA · 被引 69)
• A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR) (2022 · European Respiratory Journal · 被引 42)
• Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1 (2023 · Infectious Diseases and Therapy · 被引 19)
• The “Histoplasmosis Porto Alegre manifesto”—Addressing disseminated histoplasmosis in AIDS (2023 · PLoS neglected tropical diseases · 被引 15)
• Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study (2025 · Clinical Infectious Diseases · 被引 9)
• Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19 (2022 · medRxiv · 被引 9)